Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gas

Authors

Joore Ma
Robert A. Wolff (ORCID: https://orcid.org/0000-0002-6614-1610)
Andrea Fernández Coves
Sabine Elisabeth Grimm (ORCID: https://orcid.org/0000-0002-2175-7999)
Kevin McDermott (ORCID: https://orcid.org/0000-0002-9415-8647)
Lisa Stirk
Huiqin Yang
Nigel Armstrong
Mirre Scholte
Xiaoyu Tian

Institutions

Radboud University Nijmegen (NL)
Maastricht University Medical Centre (NL)
Radboud University Medical Center (NL)
Kleijnen Systematic Reviews (United Kingdom) (GB)

Publication Details

Journal: PharmacoEconomics
Published: 2026-01-25
DOI: https://doi.org/10.1007/s40273-026-01591-7
Primary Topic: HER2/EGFR in Cancer Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gas

Joore Ma, Robert A. Wolff, Andrea Fernández Coves, Sabine Elisabeth Grimm et al.

Jan 25, 2026

PharmacoEconomics

HER2/EGFR in Cancer Research

article

Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gas

Joore Ma, Robert A. Wolff, Andrea Fernández Coves, Sabine Elisabeth Grimm, Kevin McDermott, Lisa Stirk, Huiqin Yang, Nigel Armstrong, Mirre Scholte, Xiaoyu Tian

January 25, 2026article en

Abstract

No abstract available for this paper.

PharmacoEconomics

Radboud University Nijmegen (NL), Maastricht University Medical Centre (NL), Radboud University Medical Center (NL), Kleijnen Systematic Reviews (United Kingdom) (GB)

Zero hunger

Openalex Percentile: Top 78%

HER2/EGFR in Cancer Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gas — Joore Ma, Robert A. Wolff, et al. · PharmacoEconomics (2026) | TGRS Research Map | TGRS